400 related articles for article (PubMed ID: 17703416)
21. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept.
Borte S; Liebert UG; Borte M; Sack U
Rheumatology (Oxford); 2009 Feb; 48(2):144-8. PubMed ID: 19074187
[TBL] [Abstract][Full Text] [Related]
22. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
[TBL] [Abstract][Full Text] [Related]
23. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination.
Ovsyannikova IG; Jacobson RM; Vierkant RA; Jacobsen SJ; Pankratz VS; Poland GA
Hum Immunol; 2004 Dec; 65(12):1506-15. PubMed ID: 15603879
[TBL] [Abstract][Full Text] [Related]
24. Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine.
Seagle EE; Bednarczyk RA; Hill T; Fiebelkorn AP; Hickman CJ; Icenogle JP; Belongia EA; McLean HQ
Vaccine; 2018 Feb; 36(6):818-826. PubMed ID: 29317117
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.
Gillet Y; Steri GC; Behre U; Arsène JP; Lanse X; Helm K; Esposito S; Meister N; Desole MG; Douha M; Willems P
Vaccine; 2009 Jan; 27(3):446-53. PubMed ID: 19007835
[TBL] [Abstract][Full Text] [Related]
26. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.
Spoulou V; Giannaki M; Vounatsou M; Bakoula C; Grafakos S
Bone Marrow Transplant; 2004 Jun; 33(12):1187-90. PubMed ID: 15077129
[TBL] [Abstract][Full Text] [Related]
27. Interferon-gamma production closely related to antibody production in lymphocyte cultures stimulated with mumps virus.
Nakayama T; Unno S; Urano T; Osano M; Sasaki K; Makino S
Kitasato Arch Exp Med; 1990 Sep; 63(2-3):99-106. PubMed ID: 2128947
[TBL] [Abstract][Full Text] [Related]
28. Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy.
Aurpibul L; Puthanakit T; Sirisanthana T; Sirisanthana V
Clin Infect Dis; 2007 Sep; 45(5):637-42. PubMed ID: 17683001
[TBL] [Abstract][Full Text] [Related]
29. Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine.
LeBaron CW; Forghani B; Matter L; Reef SE; Beck C; Bi D; Cossen C; Sullivan BJ
J Infect Dis; 2009 Sep; 200(6):888-99. PubMed ID: 19659440
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of the immune status against the viruses of measles, mumps, rubella, and hepatitis B in a cohort of students from the province of Como].
Fraizzoli G; Sesana BM
Ann Ig; 1989; 1(5):1163-71. PubMed ID: 2483899
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of immunity against rubella in Iranian after mass campaign for measles-rubella vaccination on December 2003.
Hamkar R; Jalilvand S; Mokhtari-Azad T; Jelyani KN; Nategh R
Am J Infect Control; 2006 Nov; 34(9):588-92. PubMed ID: 17097454
[TBL] [Abstract][Full Text] [Related]
32. Residual susceptibility to measles among young adults in Victoria, Australia following a national targeted measles-mumps-rubella vaccination campaign.
Kelly HA; Gidding HF; Karapanagiotidis T; Leydon JA; Riddell MA
BMC Public Health; 2007 Jun; 7():99. PubMed ID: 17555601
[TBL] [Abstract][Full Text] [Related]
33. Increase of circulating CD8+CD57+ lymphocytes after measles infection but not after measles vaccination.
Aronsson B; Troye-Blomberg M; Smedman L
J Clin Lab Immunol; 2004-2005; 53():1-12. PubMed ID: 16805321
[TBL] [Abstract][Full Text] [Related]
34. Kinetics of antibody and memory B cell responses after MMR immunization in children and young adults.
Kakoulidou M; Ingelman-Sundberg H; Johansson E; Cagigi A; Farouk SE; Nilsson A; Johansen K
Vaccine; 2013 Jan; 31(4):711-7. PubMed ID: 23174196
[TBL] [Abstract][Full Text] [Related]
35. A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax.
Reisinger KS; Brown ML; Xu J; Sullivan BJ; Marshall GS; Nauert B; Matson DO; Silas PE; Schödel F; Gress JO; Kuter BJ;
Pediatrics; 2006 Feb; 117(2):265-72. PubMed ID: 16452343
[TBL] [Abstract][Full Text] [Related]
36. Incidence of mumps and immunity to measles, mumps and rubella among US military recruits, 2000-2004.
Eick AA; Hu Z; Wang Z; Nevin RL
Vaccine; 2008 Jan; 26(4):494-501. PubMed ID: 18155326
[TBL] [Abstract][Full Text] [Related]
37. A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia.
Jaber SM
Saudi Med J; 2006 Jan; 27(1):63-9. PubMed ID: 16432596
[TBL] [Abstract][Full Text] [Related]
38. Response to early measles-mumps-rubella vaccination in infants with chronic renal failure and/or receiving peritoneal dialysis.
Flynn JT; Frisch K; Kershaw DB; Sedman AB; Bunchman TE
Adv Perit Dial; 1999; 15():269-72. PubMed ID: 10682116
[TBL] [Abstract][Full Text] [Related]
39. Cell-mediated immune response to mumps virus infection in man.
Chiba Y; Dzierba JL; Morag A; Ogra PL
J Immunol; 1976 Jan; 116(1):12-5. PubMed ID: 1245735
[TBL] [Abstract][Full Text] [Related]
40. Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up.
Davidkin I; Valle M; Julkunen I
Vaccine; 1995 Nov; 13(16):1617-22. PubMed ID: 8578851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
